Back to trial details

Intake questionnaire

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Applying to Columbia University Herbert Irving Comprehensive Cancer Center · New York, New York

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Head and Neck Squamous Cell Carcinoma?
3. Are you able to travel to New York for study visits?